The FDA on Wednesday announced it is proposing revisions to physician labeling for Rx drugs to include more info about their use by pregnant and/or breast-feeding mothers.
GlaxoSmithKline’s (GSK) experimental drug Promacta (eltrombopag) failed to significantly lower bleeding in patients with the rare blood disorder it was designed to treat, the FDA said.
Eli Lilly will consolidate its global and international marketing organizations as the drugmaker undergoes a companywide initiative to reduce management layers.
A federal judge ruled against Johnson & Johnson (J&J) in a lawsuit filed by the drugmaker to halt the American Red Cross (ARC) from using the red cross emblem on first aid products sold to the public.
Shire received a warning letter from the FDA’s Division of Drug Marketing, Advertising and Communications (DDMAC) asking the drugmaker to halt distribution of specific professional marketing materials for its end stage renal disease treatment Fosrenol (lanthanum carbonate).